Finding the Best Setting for Bispecific T-Cell Engagers in Multiple Myeloma
Elucidating nonresponses to bispecific T-cell engagers may be an important research consideration in the multiple myeloma field.
Previous Post
STAT+: Eli Lilly’s key obesity pill falls short of rivals, but the company still beat on earnings
Next Post
#VisualAbstract: Perioperative Durvalumab increased Survival in Gastric and Gastroesopha-geal Junction Cancer
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago